Study of how pain relieving medications (opioids) can affect or be affected by other medications in cancer patients with pai
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2024/06/068387
- Lead Sponsor
- Kasturba Medical College Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patent attending palliative opd and receiving opioid for cancer related pain
Exclusion Criteria
cancer patient with post operative and other procedure related pain
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do CYP3A4 and CYP2D6 polymorphisms influence opioid metabolism and drug interactions in cancer patients under palliative care?
What is the comparative effectiveness of opioid-based pain management versus non-opioid analgesics in mitigating CYP450-related drug interactions among advanced cancer patients?
Which biomarkers predict susceptibility to CYP450-mediated drug interactions in cancer patients receiving opioids for pain in palliative care?
What adverse events arise from CYP450 interactions in opioid-treated cancer patients, and how are they managed in palliative care settings?
Which non-opioid medications commonly interact with CYP450 enzymes in palliative care settings for cancer-related pain, and what are their clinical implications?